Search

And we were having such a good time. Stocks were killing it in November after the election. But December turned out to be a real stinker.

Sure, the S&P 500 is only down about 1% over the past month. But that’s only because the big tech companies are still doing okay. The rest of the market is getting slapped around. Eight of the eleven S&P sectors are down in December. And many individual stocks are having a terrible month.

Stocks continue to move higher despite more tariff news. A 25% tariff was announced over the weekend on all imported steel. But the market is so far taking the news in stride during a good earnings season.

We’ll see what happens with the tariffs. But whatever happens with this latest round, it is most likely that tariff issues will remain at least a background story for most of this year. Meanwhile, stocks are being buoyed by strong earnings.

Cannabis stocks are down sharply ever since the group got its best news in decades – President Donald Trump’s December 18 executive order to reschedule the plant.

Using the AdvisorShares Pure US Cannabis exchange-traded fund (MSOS) as a proxy, the group is off 32%.

For a second straight fall, the Federal Reserve has slashed interest rates three times from September through December. The result? What was a two-decade-high federal funds rate (5.25%-5.5%) 15 months ago is now down to a far more palatable 3.50-3.75% range. That’s still higher than at any point since before the Great Recession, so from a 21st-century perspective, interest rates aren’t exactly “low.” Usually, when interest rates are this high, stocks underperform their historical norm. In fact, prior to this recent stretch, it had only occurred two other times this century. Here were the results …

Wow. Just wow. Not only has this market rally continued to forge on, it’s broadened out too. After a 14.5% gain in the first half of this year, the S&P is putting together an impressive July with a better than 3% gain so far.

The latest leg of this rally has been sparked by a better-than-expected June CPI report. Interest rate optimism abounds. Consensus now expects a Fed rate cut before the end of the year and an increased expectation that overall interest rates have peaked and are likely to trend lower for the rest of the year.

The bull market finally expanded to more than just a select few names last week, with small caps, Chinese stocks and other sectors finally getting some love. It’s a good sign for the rally’s longevity and could be a boon for our diverse portfolio. So today, we add another non-AI, non-tech stock that’s been attracting some overdue buying. It’s a big-name, resilient growth company whose stock consistently outperforms the market – and yet is undervalued at the moment. It’s a recommendation I just shared with my Cabot Value Investor readers, and today it joins our Stock of the Week portfolio.

Marijuana is the fastest-growing industry in America. And marijuana stocks are growing even faster. Here’s how to invest in this red-hot sector.

Note from Cabot Wealth Advisory Editor Elyse Andrews: Occasionally, we bring you articles from outside sources that we feel you will be interested in and benefit from. Today, we have an article from Nathan Slaughter, Chief Investment Strategist of the Half-Priced Stocks newsletter at StreetAuthority, about why you should invest in the “Best-Managed Bank in America.” I hope you enjoy it!

Airline stocks surged in June and are having a solid July, but which domestic carriers belong in first class and which are stuck in the jump seat?

During the past two months we’ve seen big Fed rate hikes (with another likely next week), multi-decade highs in inflation, some earnings duds and leading economic indicators heading sharply south, but the market has held its own, and this week, if all goes well, we could get an intermediate-term green light. That means you should have your eyes open and shopping list ready, but we’re not ready to go nuts quite yet, as we don’t anticipate signals, there’s still plenty of damage to repair and earnings season is just revving up. For now, our Market Monitor remains at a level 3.



This week’s list has another batch of biotech names (including some speculative high-flyers), though for our Top Pick, we’re going with a medical services provider that offers both growth and reliability.

Roughly 32% of respondents agreed that all eight rules were stupid. Here are some of the best answers.

The market is bouncing around a lot on a road to nowhere.

It rallies one day and then sells off again the next. The indexes fell into correction territory when Russia invaded Ukraine and have bounced around the same level since. The invasion didn’t cause much of a selloff. But the market can’t get any real traction as long as the uncertainly remains.

Throughout U.S. history, federalists and states’ rights advocates have battled it out. Federalists believe in strong centralized power. The other side wants issues to get resolved locally. Federalists are usually on the left, and states’ rights advocates are normally conservatives. But not always. It depends on the issue.